Canadian Respiratory Journal (Jan 2001)

Economic Impact of Using an Immunostimulating Agent to Prevent Severe Acute Exacerbations in Patients with Chronic Obstructive Pulmonary Disease

  • Jean-Paul Collet,
  • Thierry Ducruet,
  • Seema Haider,
  • Stan Shapiro,
  • Ann Robinson,
  • Paolo M Renzi,
  • André-Pierre Contandriopoulos,
  • Pierre Ernst

DOI
https://doi.org/10.1155/2001/508015
Journal volume & issue
Vol. 8, no. 1
pp. 27 – 33

Abstract

Read online

RATIONALE: OM-85 BV, an immunostimulant made from bacterial extracts, has been shown to reduce the risk of hospitalization for acute exacerbation in patients with chronic obstructive pulmonary disease, as well as to reduce the length of stay for all hospitalizations.